MAN Agenda2012-Technology strikeforce Agenda2012-Technology strikeforce.pdfand challenges for pharma...
7
Transcript of MAN Agenda2012-Technology strikeforce Agenda2012-Technology strikeforce.pdfand challenges for pharma...
![Page 1: MAN Agenda2012-Technology strikeforce Agenda2012-Technology strikeforce.pdfand challenges for pharma companies. Pharma may be at risk for being disengaged from the conversation with](https://reader036.fdocuments.in/reader036/viewer/2022062603/5f0a8b2d7e708231d42c270a/html5/thumbnails/1.jpg)
![Page 2: MAN Agenda2012-Technology strikeforce Agenda2012-Technology strikeforce.pdfand challenges for pharma companies. Pharma may be at risk for being disengaged from the conversation with](https://reader036.fdocuments.in/reader036/viewer/2022062603/5f0a8b2d7e708231d42c270a/html5/thumbnails/2.jpg)
Joy Houck
![Page 3: MAN Agenda2012-Technology strikeforce Agenda2012-Technology strikeforce.pdfand challenges for pharma companies. Pharma may be at risk for being disengaged from the conversation with](https://reader036.fdocuments.in/reader036/viewer/2022062603/5f0a8b2d7e708231d42c270a/html5/thumbnails/3.jpg)
![Page 4: MAN Agenda2012-Technology strikeforce Agenda2012-Technology strikeforce.pdfand challenges for pharma companies. Pharma may be at risk for being disengaged from the conversation with](https://reader036.fdocuments.in/reader036/viewer/2022062603/5f0a8b2d7e708231d42c270a/html5/thumbnails/4.jpg)
![Page 5: MAN Agenda2012-Technology strikeforce Agenda2012-Technology strikeforce.pdfand challenges for pharma companies. Pharma may be at risk for being disengaged from the conversation with](https://reader036.fdocuments.in/reader036/viewer/2022062603/5f0a8b2d7e708231d42c270a/html5/thumbnails/5.jpg)
![Page 6: MAN Agenda2012-Technology strikeforce Agenda2012-Technology strikeforce.pdfand challenges for pharma companies. Pharma may be at risk for being disengaged from the conversation with](https://reader036.fdocuments.in/reader036/viewer/2022062603/5f0a8b2d7e708231d42c270a/html5/thumbnails/6.jpg)
![Page 7: MAN Agenda2012-Technology strikeforce Agenda2012-Technology strikeforce.pdfand challenges for pharma companies. Pharma may be at risk for being disengaged from the conversation with](https://reader036.fdocuments.in/reader036/viewer/2022062603/5f0a8b2d7e708231d42c270a/html5/thumbnails/7.jpg)
!